Tomorrow, 8 May, World Ovarian Cancer Day is celebrated for the fifth consecutive year, the group of http://es.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186717&t=Recerca%20Biom%C3%A8dica%20en%20Ginecologia Biomedical Research in Gynaecology of Vall d'Hebron Research Institute (VHIR) and the https://www.vallhebron.com/es/especialidades/ginecologia" Gynaecology Service Vall d'Hebron have prepared a programme of activities for this day, including the sale of bread with chocolate for research on ovarian cancer, prepared by the master baker http://bit.ly/1iKfGNy" Daniel Jordà. This year the muffin has been named as "Chocolate Little Kisses". The traditional bread with chocolate has already become a symbol of solidarity during the day to raise awareness of the disease. "Chocolate Little Kisses" will be sold at the symbolic price of 2 euros to support initiatives to raise awareness of ovarian cancer and funds for research. The buns can be purchased on 8 May at the Arcasa cafeterias of the Vall d'Hebron, in the author's shops (http://www.panescreativos.com/" www.panescreativos.com), and at the information tables that will be placed in the lobby of the General Hospital and the Mother and Child Hospital from 10 am to 2 pm, where solidarity pins and bracelets created for the occasion by Samburu will also be on sale. The wristbands can also be purchased for 5 euros through the website of http://bit.ly/1Tidmjc" Samburu Accessories. On the other hand, the Mercado Vall d'Hebron has also joined the initiative and supports the campaign with the purchase of the buns by its stoppers, as well as http://www.srysracake.com/" Sr. y Sra. Cake who have designed the campaign poster and will support the social networking initiative. Similarly, the model Judit Mascó will also be present in the networks, showing her involvement with research into women's cancer, as she did with the solidarity scarf "Dream of Colours".Ovarian cancerOvarian cancer is the type of gynaecologic tumour with the highest mortality. It accounts for about 5% of all female tumours, is the sixth most common and fifth leading cause of cancer-related death in women. The main problem in the fight against this disease is that it does not present any guiding symptoms for doctors and patients leading to rapid diagnosis. This means that it is diagnosed in advanced stages in more than 70% of cases and the overall 5-year survival rate is less than 30%.Within the group of Biomedical Research in Gynaecology led by Dr. Antonio Gil, who is also the head of the Gynaecology Service of the Hospital, Dr. Anna Santamaria and the rest of the researchers develop lines of research to respond to the most important clinical needs related to ovarian cancer, such as early diagnosis, the evolution of the disease and its spread and the search for new therapies.In relation to treatment, Vall d'Hebron treats cases of gynaecological cancer in the Oncological Gynaecology and Lower Genital Tract Pathology Unit, which is made up of 8 professionals who attend to nearly 9,000 patients each year and perform half a thousand surgical operations.